Defence Therapeutics Inc.
DTC
Rankning i aktier
#29456
Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a... Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a biotechnology company founded in 2017. This firm focuses on pioneering biological and biosimilar therapeutic solutions for both cancer and infectious diseases. A cornerstone of its approach is the exclusive ACCUM™ technology, engineered to precisely and safely transport vaccine antigens or antibody-drug conjugates (ADCs) directly to their intended cellular targets. The company's development efforts span several key areas: novel dendritic cell vaccines for various cancers, protein-based vaccines addressing COVID-19 and other infectious ailments, and specialized antibody-drug conjugate products aimed at different cancer types. Defence Therapeutics Inc. adopted its current name in March 2020, having previously operated as Accum Therapeutics Inc.
Aktiekurs
$0.25964327
Senast synkroniserad: 2026-10-21
Marknadsvärde
$19.68M
Förändring (1 dag)
0.00%
Förändring (1 år)
-55.64%
Land
CA
Handel Defence Therapeutics Inc. (DTC)
Kategori
Healthcare
Aktiekurshistorik för Defence Therapeutics Inc. (DTC)
Högsta slutkurs: $0.27 den 2026-10-01
Lägsta slutkurs: $2.50 den 2021-05-01
Lägsta slutkurs: $2.50 den 2021-05-01
Aktiekurshistorik för Defence Therapeutics Inc. från 2021 till 2026
Årlig aktiekursutveckling
| År | Prestanda |
|---|---|
| 2026 (TTM) | -27.66% |
| 2025 | 58.71% |
| 2024 | -79.59% |
| 2023 | -28.12% |
| 2022 | -37.44% |
| 2021 | 0.00% |
Aktiekurs för liknande företag eller konkurrenter
| Företag | Aktiekurs | Förändring 1år% | Land |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $757.24 | 7.63% |
CH
|
